Spectrum Pharmaceuticals SPPI today announced the
appointment of Joseph Turgeon as Senior Vice President Sales &
Commercial Operations. Mr. Turgeon will be responsible for the
commercialization and sales of all Spectrum products; currently,
Spectrum markets FUSILEV® (levoleucovorin) for Injection;
FOLOTYN® (pralatrexate injection); and ZEVALIN®
(ibritumomab tiuxetan) Injection for intravenous use. Mr. Turgeon brings
over 25 years of pharma sales experience, including various executive
leadership roles at Amgen. He will report to Ken Keller, Executive Vice
President and Chief Operating Officer.
“With three anticancer drugs on the market now bringing
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in